Business Context and Reporting Period
This Form 8-K Current Report was filed by MIMEDX GROUP, INC. on May 20, 2016. The filing discloses a corporate governance event involving the appointment of a compensatory arrangement for a named executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation terms rather than financial performance.
Material Changes
On May 20, 2016, the Company entered into a Change in Control Severance Agreement with Alexandra O. Haden, General Counsel & Secretary. This agreement aligns her compensation terms with those of other named executive officers.
Guidance, Outlook, and Management Commentary
- Severance Terms: In the event of a "change in control" followed by termination (other than for death, disability, or "Cause") or voluntary termination for "Good Reason," Ms. Haden is entitled to a lump sum payment equal to one (1) times her annual base salary and targeted base bonus.
- Benefits: Post-termination, she receives 12 months of subsidized health insurance (subject to COBRA), life insurance, and other group benefits equivalent to active employee levels.
- Restrictive Covenants: The agreement includes non-compete and non-solicitation covenants for 12 months following termination.
- Expiration: The agreement expires three (3) years after the date of a change in control.
Investor Verification Checklist
- Review Exhibit 10.1 for the full text of the Change in Control Severance Agreement.
- Verify the specific definitions of "Cause" and "Good Reason" within the agreement.
- Confirm the current annual base salary and targeted bonus for Ms. Haden to calculate potential liability.
- Assess the total potential severance liability across all named executive officers.